Reflections on the Scope of Rights Holders in Securities Representative Litigation: — Insights from the Kangmei Pharmaceutical Case. 法学年鉴, [S. l.], v. 1, n. 2, p. 70–75, 2026. DOI: 10.63313/Law.8020. Disponível em: https://cn.erytis.com/index.php/Law/article/view/217. Acesso em: 3 jul. 2026.